Literature DB >> 1952969

Aggressive-growth basal cell carcinoma in young adults.

D J Leffell1, J T Headington, D S Wong, N A Swanson.   

Abstract

Aggressive-growth basal cell carcinoma (AG-BCC) defines a group of basal cell cancers that are histologically and clinically aggressive. This group includes morpheaform, infiltrating, and recurrent BCCs. Because of the clinical observation that the incidence of AG-BCC may be increased in patients under 35 years of age, compared with those older, we performed a retrospective study. We reviewed the pathologic findings of 3381 patients diagnosed with BCC, including 102 patients with BCC referred for Mohs surgery to determine whether AG-BCC occurs with increased frequency in patients younger than than 35 years of age. Among patients under 35 years of age, 38% of women had AG-BCC compared with 9% of women in the older age group. Similarly, 25% of men under 35 years of age had AG-BCC compared with 11% among men in the older age group. Aggressive-growth BCC is more frequently noted in patients under 35 years of age than in those older. Failure to diagnose this type of BCC, which may be clinically subtle, may lead to incomplete or inadequate treatment. Because of the tendency of these tumors to recur, greater long-term morbidity may result.

Entities:  

Mesh:

Year:  1991        PMID: 1952969

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

1.  Histopathologic variants of basal cell carcinoma correlation with sex, age and localization.

Authors:  N Puizina-Ivić; B Matoković; I Gluncić; S Maslovara; J Vela-Ljubić
Journal:  J Med Syst       Date:  1999-10       Impact factor: 4.460

2.  The Effects of Cyclin D1 and Bcl-2 Expressıon on Aggressive Behavior in Basal Cell and Basosquamous Carcinoma.

Authors:  Oya N Sivrikoz; Gülşen Kandiloğlu
Journal:  Iran J Pathol       Date:  2015

3.  Subcutaneous basal cell carcinoma: A case report.

Authors:  Tenley Voris; Robert Quinn; Mohammed Elahi; Hashim Alani
Journal:  Can J Plast Surg       Date:  2003

4.  Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma.

Authors:  Amir Amirabadi; Amirhosein Alami; Hamid Ahanchian; Nazila Ariaee; Nasrin Moazzen
Journal:  Clin Case Rep       Date:  2021-03-24

5.  Maspin expression in epithelial skin tumours: an immunohistochemical study.

Authors:  Asmaa Gaber Abdou; Alaa Hassan Maraee; Mohamed Abd El-Monaem Shoeib; Amany Mohamed Abo Saida
Journal:  J Cutan Aesthet Surg       Date:  2011-05

Review 6.  Cross-Talk between Wnt and Hh Signaling Pathways in the Pathology of Basal Cell Carcinoma.

Authors:  Felicite K Noubissi; Clement G Yedjou; Vladimir S Spiegelman; Paul B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2018-07-09       Impact factor: 3.390

7.  Early-onset basal cell carcinoma; wide case series at a single tertiary center in middle Anatolia.

Authors:  Ayse Nur Ugur Kilinc; Zeynep Bayramoglu; Yasar Unlu
Journal:  North Clin Istanb       Date:  2022-07-08

8.  E-cadherin expression in basal cell carcinoma.

Authors:  A Pizarro; N Benito; P Navarro; J Palacios; A Cano; M Quintanilla; F Contreras; C Gamallo
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

9.  Differential patterns of placental and epithelial cadherin expression in basal cell carcinoma and in the epidermis overlying tumours.

Authors:  A Pizarro; C Gamallo; N Benito; J Palacios; M Quintanilla; A Cano; F Contreras
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

10.  Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.

Authors:  Joana Cabete; Margarida Rafael; Mariana Cravo; Cecília Moura; Fernanda Sachse; Manuela Pecegueiro
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.